Position in ACAD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$32,449,678
-$5,930,924 QoQ
Shares Held
1,282,596
-25.6% QoQ
Ownership
0.744%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#25
of 354 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ACAD ranks #21 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ACAD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,449,678 | 1,282,596 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $38,380,602 | 1,724,196 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $40,935,639 | 1,532,596 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $30,933,034 | 1,449,533 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $33,384,579 | 1,547,732 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $24,533,518 | 1,477,033 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $22,506,880 | 1,226,533 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,201,216 | 403,200 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,735,000 | 476,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $10,609,562 | 573,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,761,040 | 184,000 | Shares | Sole | 2024-02-13 | |
| 2023-06-30 | $3,132,660 | 130,800 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,216,996 | 117,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,025,944 | 315,700 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $616,772 | 37,700 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $351,190 | 14,500 | Shares | Sole | 2022-05-13 | |
| 2021-03-31 | $14,989,800 | 581,000 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $9,751,104 | 182,400 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $11,116,875 | 269,500 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,438,334 | 112,200 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,568,800 | 60,800 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||